User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.

Primary tabs

Hanseeuw, Bernard [UCL] Dricot, Laurence [UCL] Lhommel, Renaud [UCL] Quenon, Lisa [UCL] Ivanoiu, Adrian [UCL]

(eng) BACKGROUND: Patients with mild cognitive impairment (MCI) are at risk for Alzheimer's dementia but the presence of amyloid (Aβ) strongly increases this risk. In clinical settings, when Aβ status is not available, different neurodegenerative markers are used to characterize MCI. The accuracy of these markers to discriminate between Aβ-and Aβ+ MCI is not yet determined. OBJECTIVE: To compare different markers of neurodegeneration in Aβ-and Aβ+ MCI, with an Aβ-elderly control (EC) group. METHODS: Patients with MCI (n = 39) and EC (n = 28) underwent MRI, 18F-FDG PET, and Aβ PET (18F-flutemetamol). We compared FDG and MRI biomarker values in cortical and hippocampal regions of interest, and using voxel-wise surface maps. We computed ROC curves discriminating between the three groups for each biomarker. RESULTS: All biomarker values were reduced in Aβ+ MCI compared to EC (p < 0.001). Aβ-MCI had low cortical metabolism (p = 0.002), but hippocampal volume, cortical thickness, and hippocampal metabolism were not significantly different between Aβ-MCI and EC (p > 0.40). Cortical metabolism best discriminated between MCI and EC (AUC = 0.92/0.86, Aβ+/Aβ-) while hippocampal volume best discriminated between Aβ-MCI and Aβ+ MCI (AUC = 0.79). CONCLUSIONS: Cortical hypometabolism was observed in both Aβ-MCI and Aβ+ MCI whereas hippocampal atrophy was mostly found in Aβ+ MCI. For MCI patients without available Aβ information, hippocampal atrophy is thus more informative about Aβ status than cortical hypometabolism.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 2016
Language Anglais
Journal information "Journal of Alzheimer's Disease" - Vol. 53, no. 2, p. 651-660 (2016)
Peer reviewed yes
Publisher I O S Press ((Netherlands) Amsterdam)
issn 1387-2877
e-issn 1875-8908
Publication status Publié
Affiliations UCL - SSS/IONS/NEUR - Clinical Neuroscience
UCL - SSS/IONS/COSY - Systems & cognitive Neuroscience
UCL - (SLuc) Service de neurologie
UCL - (SLuc) Service de médecine nucléaire
Keywords Alzheimer’s disease ; amyloid ; 18F-flutemetamol ; FDG-PET ; hippocampus ; magnetic resonance imaging ; mild cognitive impairment ; neocortex ; PALZ score
Links
  1. Jack Clifford R., Knopman David S., Weigand Stephen D., Wiste Heather J., Vemuri Prashanthi, Lowe Val, Kantarci Kejal, Gunter Jeffrey L., Senjem Matthew L., Ivnik Robert J., Roberts Rosebud O., Rocca Walter A., Boeve Bradley F., Petersen Ronald C., An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease, 10.1002/ana.22628
  2. Albert Marilyn S., DeKosky Steven T., Dickson Dennis, Dubois Bruno, Feldman Howard H., Fox Nick C., Gamst Anthony, Holtzman David M., Jagust William J., Petersen Ronald C., Snyder Peter J., Carrillo Maria C., Thies Bill, Phelps Creighton H., The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease, 10.1016/j.jalz.2011.03.008
  3. Klunk William E., Engler Henry, Nordberg Agneta, Wang Yanming, Blomqvist Gunnar, Holt Daniel P., Bergström Mats, Savitcheva Irina, Huang Guo-Feng, Estrada Sergio, Ausén Birgitta, Debnath Manik L., Barletta Julien, Price Julie C., Sandell Johan, Lopresti Brian J., Wall Anders, Koivisto Pernilla, Antoni Gunnar, Mathis Chester A., Långström Bengt, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B : Imaging Amyloid in AD with PIB, 10.1002/ana.20009
  4. Ma Yan, Zhang Shuo, Li Jing, Zheng Dong-Ming, Guo Yang, Feng Juan, Ren Wei-Dong, Predictive Accuracy of Amyloid Imaging for Progression From Mild Cognitive Impairment to Alzheimer Disease With Different Lengths of Follow-up : A Meta-analysis, 10.1097/md.0000000000000150
  5. Fischer P., Jungwirth S., Zehetmayer S., Weissgram S., Hoenigschnabl S., Gelpi E., Krampla W., Tragl K. H., Conversion from subtypes of mild cognitive impairment to Alzheimer dementia, 10.1212/01.wnl.0000252358.03285.9d
  6. Wolk David A., Price Julie C., Saxton Judy A., Snitz Beth E., James Jeffrey A., Lopez Oscar L., Aizenstein Howard J., Cohen Ann D., Weissfeld Lisa A., Mathis Chester A., Klunk William E., DeKosky Steven T., Amyloid imaging in mild cognitive impairment subtypes, 10.1002/ana.21598
  7. Ivanoiu, J Alzheimers Dis, 43, 835 (2015)
  8. Caroli A., Prestia A., Galluzzi S., Ferrari C., van der Flier W. M., Ossenkoppele R., Van Berckel B., Barkhof F., Teunissen C., Wall A. E., Carter S. F., Scholl M., Choo I. H., Grimmer T., Redolfi A., Nordberg A., Scheltens P., Drzezga A., Frisoni G. B., , Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression, 10.1212/wnl.0000000000001209
  9. Folstein Marshal F., Folstein Susan E., McHugh Paul R., “Mini-mental state”, 10.1016/0022-3956(75)90026-6
  10. Vandenberghe Rik, Van Laere Koen, Ivanoiu Adrian, Salmon Eric, Bastin Christine, Triau Eric, Hasselbalch Steen, Law Ian, Andersen Allan, Korner Alex, Minthon Lennart, Garraux Gaëtan, Nelissen Natalie, Bormans Guy, Buckley Chris, Owenius Rikard, Thurfjell Lennart, Farrar Gill, Brooks David J., 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial : 18F-Flutemetamol Phase 2 Trial, 10.1002/ana.22068
  11. Varrone Andrea, Asenbaum Susanne, Vander Borght Thierry, Booij Jan, Nobili Flavio, Någren Kjell, Darcourt Jacques, Kapucu Özlem L., Tatsch Klaus, Bartenstein Peter, Van Laere Koen, EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2, 10.1007/s00259-009-1264-0
  12. Herholz K., Westwood S., Haense C., Dunn G., Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment, 10.2967/jnumed.111.090902
  13. Hammers Alexander, Allom Richard, Koepp Matthias J., Free Samantha L., Myers Ralph, Lemieux Louis, Mitchell Tejal N., Brooks David J., Duncan John S., Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe, 10.1002/hbm.10123
  14. Fischl Bruce, Salat David H., Busa Evelina, Albert Marilyn, Dieterich Megan, Haselgrove Christian, van der Kouwe Andre, Killiany Ron, Kennedy David, Klaveness Shuna, Montillo Albert, Makris Nikos, Rosen Bruce, Dale Anders M., Whole Brain Segmentation, 10.1016/s0896-6273(02)00569-x
  15. Dickerson Bradford C., Bakkour Akram, Salat David H., Feczko Eric, Pacheco Jenni, Greve Douglas N., Grodstein Fran, Wright Christopher I., Blacker Deborah, Rosas H. Diana, Sperling Reisa A., Atri Alireza, Growdon John H., Hyman Bradley T., Morris John C., Fischl Bruce, Buckner Randy L., The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals, 10.1093/cercor/bhn113
  16. Manolio T. A., Kronmal R. A., Burke G. L., Poirier V., O'Leary D. H., Gardin J. M., Fried L. P., Steinberg E. P., Bryan R. N., Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study, 10.1161/01.str.25.2.318
  17. Mulder Emma R., de Jong Remko A., Knol Dirk L., van Schijndel Ronald A., Cover Keith S., Visser Pieter J., Barkhof Frederik, Vrenken Hugo, Hippocampal volume change measurement: Quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST, 10.1016/j.neuroimage.2014.01.058
  18. Pagani M., Dessi B., Morbelli S., Brugnolo A., Salmaso D., Piccini A., Mazzei D., Villavecchia G., Larsson S.A., Rodriguez G., Nobili F., MCI Patients Declining and Not-Declining at Mid-Term Follow-Up: FDG-PET Findings, 10.2174/156720510791162368
  19. Dickerson Bradford, Biomarker-based prediction of progression in MCI: comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau, 10.3389/fnagi.2013.00055
  20. Morbelli, J Alzheimers Dis, 44, 815 (2015)
  21. Pagani M., De Carli F., Morbelli S., Öberg J., Chincarini A., Frisoni G.B., Galluzzi S., Perneczky R., Drzezga A., van Berckel B.N.M., Ossenkoppele R., Didic M., Guedj E., Brugnolo A., Picco A., Arnaldi D., Ferrara M., Buschiazzo A., Sambuceti G., Nobili F., Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study, 10.1016/j.nicl.2014.11.007
  22. Cohen Ann D., Klunk William E., Early detection of Alzheimer's disease using PiB and FDG PET, 10.1016/j.nbd.2014.05.001
  23. Wu Liyong, Rowley Jared, Mohades Sara, Leuzy Antoine, Dauar Marina Tedeschi, Shin Monica, Fonov Vladimir, Jia Jianping, Gauthier Serge, Rosa-Neto Pedro, , Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment, 10.1371/journal.pone.0047905
  24. Li Yi, Rinne Juha O., Mosconi Lisa, Pirraglia Elizabeth, Rusinek Henry, DeSanti Susan, Kemppainen Nina, Någren Kjell, Kim Byeong-Chae, Tsui Wai, de Leon Mony J., Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease, 10.1007/s00259-008-0833-y
  25. Brück A., Virta J. R., Koivunen J., Koikkalainen J., Scheinin N. M., Helenius H., Någren K., Helin S., Parkkola R., Viitanen M., Rinne J. O., [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment, 10.1007/s00259-013-2478-8
  26. Cohen A. D., Price J. C., Weissfeld L. A., James J., Rosario B. L., Bi W., Nebes R. D., Saxton J. A., Snitz B. E., Aizenstein H. A., Wolk D. A., DeKosky S. T., Mathis C. A., Klunk W. E., Basal Cerebral Metabolism May Modulate the Cognitive Effects of A  in Mild Cognitive Impairment: An Example of Brain Reserve, 10.1523/jneurosci.3669-09.2009
  27. Teipel Stefan J., Kurth Jens, Krause Bernd, Grothe Michel J., The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment — Beyond classical regression, 10.1016/j.nicl.2015.05.006
  28. Tiepolt Solveig, Patt Marianne, Hoffmann Karl-Titus, Schroeter Matthias L., Sabri Osama, Barthel Henryk, Alzheimer’s Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject, 10.3233/jad-150163
  29. Ashraf A., Fan Z., Brooks D. J., Edison P., Cortical hypermetabolism in MCI subjects: a compensatory mechanism?, 10.1007/s00259-014-2919-z
  30. Banzo Ignacio, Jiménez-Bonilla Julio, Ortega-Nava Fernando, Quirce Remedios, Martínez-Rodríguez Isabel, de Arcocha-Torres María, Rodríguez Eloy, Vázquez José L., Sánchez Pascual J., Martínez-Amador Néstor, Ibañez-Bravo Susana, Carril José M., Amyloid imaging with 11C-PIB PET/CT and glucose metabolism with 18F-FDG PET/CT in a study on cognitive impairment in the clinical setting : , 10.1097/mnm.0000000000000042
  31. Clerici, Q J Nucl Med Mol Imaging, 53, 646 (2009)
  32. Wisse Laura E.M., Butala Nirali, Das Sandhitsu R., Davatzikos Christos, Dickerson Bradford C., Vaishnavi Sanjeev N., Yushkevich Paul A., Wolk David A., Suspected non-AD pathology in mild cognitive impairment, 10.1016/j.neurobiolaging.2015.08.029
  33. Ossenkoppele Rik, Jansen Willemijn J., Rabinovici Gil D., Knol Dirk L., van der Flier Wiesje M., van Berckel Bart N. M., Scheltens Philip, Visser Pieter Jelle, Verfaillie Sander C. J., Zwan Marissa D., Adriaanse Sofie M., Lammertsma Adriaan A., Barkhof Frederik, Jagust William J., Miller Bruce L., Rosen Howard J., Landau Susan M., Villemagne Victor L., Rowe Christopher C., Lee Dong Y., Na Duk L., Seo Sang W., Sarazin Marie, Roe Catherine M., Sabri Osama, Barthel Henryk, Koglin Norman, Hodges John, Leyton Cristian E., Vandenberghe Rik, van Laere Koen, Drzezga Alexander, Forster Stefan, Grimmer Timo, Sánchez-Juan Pascual, Carril Jose M., Mok Vincent, Camus Vincent, Klunk William E., Cohen Ann D., Meyer Philipp T., Hellwig Sabine, Newberg Andrew, Frederiksen Kristian S., Fleisher Adam S., Mintun Mark A., Wolk David A., Nordberg Agneta, Rinne Juha O., Chételat Gaël, Lleo Alberto, Blesa Rafael, Fortea Juan, Madsen Karine, Rodrigue Karen M., Brooks David J., Prevalence of Amyloid PET Positivity in Dementia Syndromes : A Meta-analysis, 10.1001/jama.2015.4669
  34. Huijbers Willem, Mormino Elizabeth C., Schultz Aaron P., Wigman Sarah, Ward Andrew M., Larvie Mykol, Amariglio Rebecca E., Marshall Gad A., Rentz Dorene M., Johnson Keith A., Sperling Reisa A., Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression, 10.1093/brain/awv007
  35. Jack Clifford R., Lowe Val J., Senjem Matthew L., Weigand Stephen D., Kemp Bradley J., Shiung Maria M., Knopman David S., Boeve Bradley F., Klunk William E., Mathis Chester A., Petersen Ronald C., 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment, 10.1093/brain/awm336
  36. Mormino E. C., Kluth J. T., Madison C. M., Rabinovici G. D., Baker S. L., Miller B. L., Koeppe R. A., Mathis C. A., Weiner M. W., Jagust W. J., , Episodic memory loss is related to hippocampal-mediated  -amyloid deposition in elderly subjects, 10.1093/brain/awn320
  37. Ye Byoung Seok, Seo Sang Won, Kim Chi Hun, Jeon Seun, Kim Geon Ha, Noh Young, Cho Hanna, Yoon Cindy W., Kim Hee Jin, Jang Eun Young, Lee Jeongmin, Kim Jung-Hyun, Chin Juhee, Lee Jong Min, Kim Jeong-Hun, Seong Joon-kyung, Kim Chang-Hun, Choe Yearn Seong, Lee Kyung Han, Na Duk L., Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment, 10.1016/j.neurobiolaging.2013.08.017
  38. Barnes Josephine, Bartlett Jonathan W., van de Pol Laura A., Loy Clement T., Scahill Rachael I., Frost Chris, Thompson Paul, Fox Nick C., A meta-analysis of hippocampal atrophy rates in Alzheimer's disease, 10.1016/j.neurobiolaging.2008.01.010
  39. La Joie Renaud, Perrotin Audrey, de La Sayette Vincent, Egret Stéphanie, Doeuvre Loïc, Belliard Serge, Eustache Francis, Desgranges Béatrice, Chételat Gaël, Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia, 10.1016/j.nicl.2013.08.007
  40. Hutton Chloe, Draganski Bogdan, Ashburner John, Weiskopf Nikolaus, A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging, 10.1016/j.neuroimage.2009.06.043
  41. Da Xiao, Toledo Jon B., Zee Jarcy, Wolk David A., Xie Sharon X., Ou Yangming, Shacklett Amanda, Parmpi Paraskevi, Shaw Leslie, Trojanowski John Q., Davatzikos Christos, Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers, 10.1016/j.nicl.2013.11.010
  42. Ossenkoppele R., van der Flier W. M., Verfaillie S. C. J., Vrenken H., Versteeg A., van Schijndel R. A., Sikkes S. A., Twisk J., Adriaanse S. M., Zwan M. D., Boellaard R., Windhorst A. D., Barkhof F., Scheltens P., Lammertsma A. A., van Berckel B. N. M., Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions, 10.1212/wnl.0000000000000432
  43. De Santi Susan, de Leon Mony J, Rusinek Henry, Convit Antonio, Tarshish Chaim Y, Roche Alexandra, Tsui Wai Hon, Kandil Emad, Boppana Madhu, Daisley Katherine, Wang Gene Jack, Schlyer David, Fowler Joanna, Hippocampal formation glucose metabolism and volume losses in MCI and AD, 10.1016/s0197-4580(01)00230-5
  44. Nestor Peter J., Fryer Tim D., Smielewski Peter, Hodges John R., Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment, 10.1002/ana.10669
  45. Mosconi L., Tsui W. -H., De Santi S., Li J., Rusinek H., Convit A., Li Y., Boppana M., de Leon M. J., Reduced hippocampal metabolism in MCI and AD: Automated FDG-PET image analysis, 10.1212/01.wnl.0000163856.13524.08
  46. Mevel Katell, Desgranges Béatrice, Baron Jean-Claude, Landeau Brigitte, De la Sayette Vincent, Viader Fausto, Eustache Francis, Chételat Gaël, Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches, 10.1016/j.neuroimage.2007.04.048
  47. de Leon M. J., Convit A., Wolf O. T., Tarshish C. Y., DeSanti S., Rusinek H., Tsui W., Kandil E., Scherer A. J., Roche A., Imossi A., Thorn E., Bobinski M., Caraos C., Lesbre P., Schlyer D., Poirier J., Reisberg B., Fowler J., Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET), 10.1073/pnas.191044198
  48. Chetelat G., Desgranges B., Landeau B., Mezenge F., Poline J. B., de la Sayette V., Viader F., Eustache F., Baron J.-C., Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease, 10.1093/brain/awm288
  49. Kawachi Takashi, Ishii Kazunari, Sakamoto Setsu, Sasaki Masahiro, Mori Tetsuya, Yamashita Fumio, Matsuda Hiroshi, Mori Etsuro, Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer’s disease, 10.1007/s00259-005-0050-x
  50. Ishii Kazunari, Sasaki Hiroki, Kono Atsushi K., Miyamoto Naokazu, Fukuda Tetsuya, Mori Etsuro, Comparison of gray matter and metabolic reduction in mild Alzheimer’s disease using FDG-PET and voxel-based morphometric MR studies, 10.1007/s00259-004-1740-5
Bibliographic reference Hanseeuw, Bernard ; Dricot, Laurence ; Lhommel, Renaud ; Quenon, Lisa ; Ivanoiu, Adrian. Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.. In: Journal of Alzheimer's Disease, Vol. 53, no. 2, p. 651-660 (2016)
Permanent URL http://hdl.handle.net/2078.1/174582